vancomycin has been researched along with Cancer, Second Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattoir, V; Dargère, S; Daurel, C; Fines-Guyon, M; Margat, E; Michon, J; Verdon, R | 1 |
| Higa, T; Kami, M; Kanda, Y; Kawamoto, H; Makimoto, A; Matsubara, H; Mineishi, S; Ohira, M; Takaue, Y; Tanosaki, R | 1 |
2 other study(ies) available for vancomycin and Cancer, Second Primary
| Article | Year |
|---|---|
[Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Communicable Diseases, Emerging; Community-Acquired Infections; Endocarditis, Bacterial; Female; Gastrectomy; Genes, Bacterial; Gentamicins; Humans; Lymphoma, B-Cell, Marginal Zone; Methicillin-Resistant Staphylococcus aureus; Mitral Valve Insufficiency; Multiple Sclerosis; Neoplasms, Second Primary; Ovarian Neoplasms; Postoperative Complications; Rifampin; Staphylococcal Infections; Stomach Neoplasms; Vancomycin | 2013 |
Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Child, Preschool; Humans; Infusions, Intravenous; Injections, Spinal; Leukemia, Myeloid, Acute; Male; Meningoencephalitis; Methicillin Resistance; Neoplasms, Second Primary; Staphylococcal Infections; Staphylococcus aureus; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vancomycin | 2003 |